Making sense of the AI research
landscape: a practical guide for market
research leaders navigating AI-powered
qualitative methodologies.
By DOCREPLAY.ai
ABSTRACT
The pharmaceutical market research industry is undergoing a seismic shift. Artificial intelligence has
moved from a futuristic promise to an operational reality, and every stakeholder from insights teams
to C-suite executives are feeling the pressure to adopt. The mandate is clear: go faster, produce
better results, and do it more cost-effectively.
Yet for most market research professionals, the AI landscape feels less like an open highway and
more like a fog bank. Vendors are everywhere, each claiming a different flavor of “AI-powered”
capability. Traditional research firms are retrofitting decades-old methodologies with new technology.
Meanwhile, entirely new approaches are emerging that don’t just augment the old ways, they
fundamentally reimagine how qualitative insights are generated.
This white paper cuts through the noise. It provides a clear, educational framework for
understanding the different AI-enabled research approaches available today, when each approach is
best suited, and critically where the industry’s most significant blind spot remains: the gap between
summarization and true quantification of qualitative data.
THE PRESSURE TO ADOPT AI IN MARKET RESEARCH
The pharmaceutical market research industry is undergoing a seismic shift. Artificial intelligence has
moved from a futuristic promise to an operational reality, and every stakeholder from insights teams
to C-suite executives are feeling the pressure to adopt. The mandate is clear: go faster, produce
better results, and do it more cost-effectively.
This white paper cuts through the noise. It provides a clear, educational framework for
understanding the different AI-enabled research approaches available today, when each approach is
best suited, and critically where the industry’s most significant blind spot remains: the gap between
summarization and true quantification of qualitative data.
The question is no longer whether to adopt AI in qualitative research. The question is
which approach matches which research objective.
MAPPING THE AI RESEARCH LANDSCAPE
The pharmaceutical market research industry is undergoing a seismic shift. Artificial intelligence has
moved from a futuristic promise to an operational reality, and every stakeholder from insights teams
to C-suite executives are feeling the pressure to adopt. The mandate is clear: go faster, produce
better results, and do it more cost-effectively.To make sense of the landscape, it helps to organize the available approaches into distinct
categories. Each occupies a different position based on two critical dimensions: the scale of data
collection and the d
1. Traditional Human-Led Research
The pharmaceutical market research industry is undergoing a seismic shift. Artificial intelligence has
moved from a futuristic promise to an operational reality, and every stakeholder from insights teams
to C-suite executives are feeling the pressure to adopt. The mandate is clear: go faster, produce
better results, and do it more cost-effectively.
This white paper cuts through the noise. It provides a clear, educational framework for
understanding the different AI-enabled research approaches available today, when each approach is
best suited, and critically where the industry’s most significant blind spot remains: the gap between
summarization and true quantification of qualitative data.
2. AI as Moderator
The pharmaceutical market research industry is undergoing a seismic shift. Artificial intelligence has
moved from a futuristic promise to an operational reality, and every stakeholder from insights teams
to C-suite executives are feeling the pressure to adopt. The mandate is clear: go faster, produce
better results, and do it more cost-effectively.
This white paper cuts through the noise. It provides a clear, educational framework for
understanding the different AI-enabled research approaches available today, when each approach is
best suited, and critically where the industry’s most significant blind spot remains: the gap between
summarization and true quantification of qualitative data.
| Approach | Typical Sample | Speed | Analytical Output | Cost | Best For |
|---|---|---|---|---|---|
| Human-Led IDIs | 15–30 | 6–8 weeks | Summary | $$$$ | Exploratory, early-stage discovery |
| AI Moderator | 20–60 | 2–4 weeks | Surface analysis | $$ | Exploratory with speed/cost needs |
When 30 Works: Exploration and Discovery
Small samples excel when you’re exploring undefined territory:
- Uncovering unexpected needs
- Understanding complex emotional drivers
- Generating hypotheses for future testing
About DOCREPLAY.ai
DOCREPLAY.ai delivers AI-powered strategic direction through voice intelligence for pharmaceutical
market research. When you have defined strategic questions requiring rapid decisive answers –
testing creative concepts, evaluating messaging, or answering business questions, DOCREPLAY.ai
delivers 68 physician or patient perspectives in 20 days with statistical rigor that drives confident
decisions
For exploratory research requiring deep qualitative understanding, we partner with leading qualitative
research firms. For strategic decisions requiring breadth and statistical confidence, we deliver the
scale and speed that evidence-based decisions demand.
Contact us: [email protected]
© 2026 DOCREPLAY.ai. All rights reserved. This white paper may not be reproduced,
distributed, or transmitted in any form without prior written permission from DOCREPLAY.ai.